NM_004934.5:c.644-10433G>A
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_004934.5(CDH18):c.644-10433G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.647 in 152,024 control chromosomes in the GnomAD database, including 32,327 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.65   (  32327   hom.,  cov: 32) 
Consequence
 CDH18
NM_004934.5 intron
NM_004934.5 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -1.36  
Publications
2 publications found 
Genes affected
 CDH18  (HGNC:1757):  (cadherin 18) This gene encodes a type II classical cadherin from the cadherin superfamily of integral membrane proteins that mediate calcium-dependent cell-cell adhesion. Mature cadherin proteins are composed of a large N-terminal extracellular domain, a single membrane-spanning domain, and a small, highly conserved C-terminal cytoplasmic domain. Type II (atypical) cadherins are defined based on their lack of a HAV cell adhesion recognition sequence specific to type I cadherins. This particular cadherin is expressed specifically in the central nervous system and is putatively involved in synaptic adhesion, axon outgrowth and guidance. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2014] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.02). 
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.743  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.647  AC: 98290AN: 151906Hom.:  32314  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
98290
AN: 
151906
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome   AF:  0.647  AC: 98336AN: 152024Hom.:  32327  Cov.: 32 AF XY:  0.646  AC XY: 47996AN XY: 74300 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
98336
AN: 
152024
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
47996
AN XY: 
74300
show subpopulations 
African (AFR) 
 AF: 
AC: 
21310
AN: 
41452
American (AMR) 
 AF: 
AC: 
9967
AN: 
15270
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
2345
AN: 
3468
East Asian (EAS) 
 AF: 
AC: 
3806
AN: 
5162
South Asian (SAS) 
 AF: 
AC: 
3680
AN: 
4820
European-Finnish (FIN) 
 AF: 
AC: 
6789
AN: 
10556
Middle Eastern (MID) 
 AF: 
AC: 
203
AN: 
292
European-Non Finnish (NFE) 
 AF: 
AC: 
48190
AN: 
67984
Other (OTH) 
 AF: 
AC: 
1411
AN: 
2110
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.504 
Heterozygous variant carriers
 0 
 1765 
 3530 
 5295 
 7060 
 8825 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 802 
 1604 
 2406 
 3208 
 4010 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
2652
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.